Mereo BioPharma (MREO) Leases (2022 - 2025)
Historic Leases for Mereo BioPharma (MREO) over the last 4 years, with Q3 2025 value amounting to $378000.0.
- Mereo BioPharma's Leases fell 5841.58% to $378000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $378000.0, marking a year-over-year decrease of 5841.58%. This contributed to the annual value of $727000.0 for FY2024, which is 4160.64% down from last year.
- As of Q3 2025, Mereo BioPharma's Leases stood at $378000.0, which was down 5841.58% from $522000.0 recorded in Q2 2025.
- In the past 5 years, Mereo BioPharma's Leases ranged from a high of $1.7 million in Q4 2022 and a low of $378000.0 during Q3 2025
- In the last 4 years, Mereo BioPharma's Leases had a median value of $909000.0 in 2024 and averaged $910777.8.
- Its Leases has fluctuated over the past 5 years, first tumbled by 2676.47% in 2023, then tumbled by 5841.58% in 2025.
- Quarter analysis of 4 years shows Mereo BioPharma's Leases stood at $1.7 million in 2022, then decreased by 26.76% to $1.2 million in 2023, then tumbled by 41.61% to $727000.0 in 2024, then plummeted by 48.01% to $378000.0 in 2025.
- Its Leases was $378000.0 in Q3 2025, compared to $522000.0 in Q2 2025 and $622000.0 in Q1 2025.